SAM
TNDM icon

Silvercrest Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Silvercrest Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-346,160
Closed -$6.45M – 870
2025
Q2 		$6.45M Buy
346,160
+65
+0% +$1.29K 0.04% 389
2025
Q1 		$6.63M Sell
346,095
-470
-0.1% -$13.8K 0.05% 361
2024
Q4 		$12.5M Buy
346,565
+78,347
+29% +$2.65M 0.08% 250
2024
Q3 		$11.4M Sell
268,218
-1,547
-0.6% -$65.6K 0.08% 243
2024
Q2 		$10.9M Buy
269,765
+3,607
+1% +$150K 0.07% 244
2024
Q1 		$9.42M Buy
266,158
+10,907
+4% +$292K 0.06% 270
2023
Q4 		$7.55M Buy
255,251
+179
+0.1% +$3.71K 0.05% 297
2023
Q3 		$5.3M Buy
255,072
+63,373
+33% +$1.74M 0.04% 351
2023
Q2 		$4.7M Buy
191,699
+28,095
+17% +$904K 0.03% 378
2023
Q1 		$6.64M Buy
163,604
+22,936
+16% +$950K 0.05% 292
2022
Q4 		$6.32M Sell
140,668
-2,169
-2% -$98.2K 0.05% 296
2022
Q3 		$6.83M Buy
142,837
+55,784
+64% +$3.06M 0.06% 276
2022
Q2 		$5.15M Sell
87,053
-4,715
-5% -$387K 0.04% 329
2022
Q1 		$10.7M Buy
91,768
+1,093
+1% +$128K 0.07% 247
2021
Q4 		$13.6M Buy
90,675
+547
+0.6% +$73.8K 0.09% 223
2021
Q3 		$10.8M Sell
90,128
-1,355
-1% -$149K 0.07% 256
2021
Q2 		$8.91M Sell
91,483
-205
-0.2% -$18.3K 0.06% 295
2021
Q1 		$8.09M Buy
91,688
+37,951
+71% +$3.53M 0.05% 290
2020
Q4 		$5.14M Sell
53,737
-18,805
-26% -$1.94M 0.04% 361
2020
Q3 		$8.23M Sell
72,542
-1,237
-2% -$130K 0.07% 248
2020
Q2 		$7.3M Sell
73,779
-624
-0.8% -$49.8K 0.06% 251
2020
Q1 		$4.79M Buy
+74,403
New +$5.21M 0.05% 284

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Silvercrest Asset Management's TNDM Position: Q3 2025 in Review

Silvercrest Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 346,160 shares — an estimated $6.45M sold.

Silvercrest Asset Management first reported a position in TNDM in Q1 2020 and held it in 22 quarters. The position peaked at $13.6M in Q4 2021. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Silvercrest Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Silvercrest Asset Management sold 346,160 Tandem Diabetes Care shares in Q3 2025, an estimated $6.45M.
  • Silvercrest Asset Management first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 22 quarters.
  • Silvercrest Asset Management's Tandem Diabetes Care position peaked at $13.6M in Q4 2021.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Silvercrest Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.